Connect with us

Press Releases

Alimera CEO to Retire; New Chief Named

mm

Published

on

(PRESS RELEASE) ATLANTA – Alimera Sciences Inc., a company focused on prescription ophthalmic pharmaceuticals, has appointed Rick Eiswirth as CEO, effective Jan. 2.

Eiswirth will also retain his title of president and join Alimera’s board of directors. Alimera co-founder Dan Myers will retire as CEO, effective Jan. 2, and will serve as non-executive chairman of the board and consultant to the company.

“Dan has piloted the company to significant growth and success during his tenure and we thank him for his strong leadership,” said James Largent, current chairman of the board, who will become lead independent director. “The Board and I have the utmost confidence in the leadership of Rick Eiswirth as he assumes the role of CEO. Rick is a veteran of the company and has served as President for three years and CFO since 2005. His outstanding performance in these roles indicates the company is in excellent hands.”

Myers said, “It has been a great honor to have co-founded and led this company over the last 15 years, and I am extremely proud of the value we have created together for patients and customers. I want to thank each of our employees and our partners for their ongoing commitment to helping people with diabetic macular edema and other diseases of the back of the eye. This is the right time for me personally, and for the company, to transition to the next generation of leadership. Rick is the right person for the role.”

Eiswirth said, “I am incredibly excited to assume this new role and am grateful to Dan for his guidance and his confidence in providing me with increased leadership roles here at Alimera. We have a creative, talented team in place that is focused on seeking growth opportunities and maximizing the value of our ILUVIEN asset. The opportunity that lies ahead for Alimera is significant, and the ability to lead this next chapter is both humbling and incredibly energizing.”

As part of the executive transition plan, Largent will step down as chairman of the board and become lead independent director. Largent has served on the company’s board of directors since 2011 and as chairman since 2015.

Advertisement

Phil Jones, current vice president of finance, will be promoted to the role of chief financial officer. Jones joined Alimera in 2015 as the corporate controller and was promoted to vice president of finance in 2016.

Dave Holland, currently senior vice president, sales and marketing U.S., will assume the titles of chief marketing officer and senior vice president, corporate communications and managed markets. Holland co-founded the company with Myers in 2003 and has been with Alimera in various roles since that time.

Philip Ashman, currently senior vice president, managing director Europe, will add the oversight of operations, including quality assurance, manufacturing and logistics, to his role, and assume the titles of chief operating officer and senior vice president, commercial operations Europe. Ashman joined the Company in 2013 as managing director of Europe.

“The growth of Alimera in the future will require great teamwork,” Eiswirth added. “Dave, Philip and Phil have all made valuable contributions to drive Alimera to where it is today, and I am excited for their new responsibilities as the team starts a new chapter for the Company.”

Also as part of the executive transition plan, Ken Green, currently senior vice president, chief scientific officer and global head of research and development, has announced his retirement to be effective March 31, 2019. Green will continue as a consultant to the company.

Advertisement

Advertisement

SPONSORED VIDEO

SPONSORED BY SAFILO

Max Mara —True Elegance in Eyewear

Whether energizing the classics or creating imaginative new silhouettes, Max Mara designs dynamic eyewear for today’s woman. The Fall/Winter 2018 collections continue the company’s sartorial heritage with eyewear that effortlessly blends fashion with innovation to create elegant, timeless designs. Be inspired—watch the 2018 Fall/Winter Collection video!

Promoted Headlines

Want more INVISION? Subscribe to our newsletter.

Comment

Press Releases

CooperVision Expands Myopia Management Team

The company added 2 eyecare-industry veterans.

mm

Published

on

Elizabeth Lumb and Chi Shing Fan

(PRESS RELEASE) PLEASANTON, CA — Responding to growing global interest in myopia management and its MiSight 1 day contact lenses, CooperVision’s Specialty EyeCare Division has named two eyecare-industry veterans to newly established professional services roles.

Elizabeth Lumb has been appointed as head of professional services, MiSight 1 day, EMEA (Europe, Middle East and Africa) and global brand manager for the lens. She joined the organization in 2013, serving as professional services training manager for Europe. Earlier in her career, she worked at Eurolens Research under the directorship of Professor Nathan Efron, conducting contact lens clinical research trials with findings presented at the American Academy of Optometry and BCLA conferences. Lumb was also a senior optometrist with Boots Opticians. She is based in the UK.

Chi Shing Fan, who led the test market introduction of MiSight in Hong Kong, has been appointed as professional service and commercial lead, MiSight & Specialty Business, Asia Pacific. He joined CooperVision in 2009, serving as professional services director, Asia Pacific and as the region’s frequent replacement category lead. Previously, he held regional professional services roles with Bausch + Lomb and CIBA Vision. Fan is based in Hong Kong.

“Closely partnering with eye care professionals is essential to advancing myopia management best practices, including embracing groundbreaking, proven technologies and educating parents,” said Stuart Cockerill, senior director, myopia management at CooperVision. “For more than two decades, Fan and Liz have earned the respect of colleagues and clinicians across Asia Pacific and EMEA. Their new focus will further accelerate adoption of MiSight, helping more children and their families benefit from this innovative approach.”

The company has also recently appointed MiSight Professional Services leads for the UK, France and Iberia. It intends to staff similar roles in Germany-Austria-Switzerland, Hong Kong and Singapore, aiding the establishment of myopia management best practices in those markets.

CooperVision MiSight is the world’s first 1-day soft contact lens shown to substantially slow the progression of myopia in children. In a global multicenter study, it has been shown to reduce the progression of myopia by 59 percent (SE) and 53 percent (eye elongation) over three years when compared to a group of children wearing a single vision 1-day lens.

The prevalence of myopia is projected to increase from approximately two billion people worldwide in 2010 to almost 5 billion people in 20503, bringing with it near- and long-term health challenges. Not only does it create blurred vision, but also increases the likelihood of conditions later in life such as glaucoma, cataract, retinal detachment and myopic maculopathy if not addressed.

Continue Reading

Press Releases

CooperVision Raises $262K+ for World Sight Day Challenge

It’s passed $1M in cumulative funds raised.

mm

Published

on

(PRESS RELEASE) PLEASANTON, CA — Following an employee fundraising campaign that eclipsed previous efforts, CooperVision has donated $262,000 to Optometry Giving Sight in support of the 2018 World Sight Day Challenge. The company has now surpassed the $1 million milestone in cumulative funds raised during the past seven years for the World Sight Day Challenge.

Employees increased year-over-year giving by more than 35 percent, supported by a matching commitment from the company. More than 40 CooperVision sites and teams created multiple activities to engage employees, drive awareness and generate donations. In addition to sales of cause-branded merchandise, initiatives included artwork auctions, bake sales, jeans days, raffles, barbeques and a World Sight Day walkathon.

“The incredible generosity displayed by our global employees will help to ensure much needed vision care for thousands of adults and children in need,” said Dan McBride, president, CooperVision. “Our record-breaking 2018 World Sight Day Challenge donation represents approximately 52,000 eye exams for people around the world who could otherwise be at risk for a range of vision challenges. The expert care they’ll receive will not only provide near-term benefits, but in many cases a lifetime of greater opportunity through the gift of sight.”

“Our partnership with CooperVision shows the depth of the company’s commitment to improving vision, and the passion and energy of its employees as they rally behind our mission,” said Christina Sanko, senior director of development, Optometry Giving Sight. “That visionary perspective sets CooperVision apart, and we can’t thank them enough.”

CooperVision is a longstanding Optometry Giving Sight partner and Global Gold Sponsor. Beyond its World Sight Day Challenge initiative, the company contributes substantial funds through a patient rebate donation program in the United States, which has totaled more than $175,000 in 2018.

Other Optometry Giving Sight-affiliated programs from CooperVision include LensFerry donations for completed patient annual subscriptions and Europe’s One Bright Vision cause-related marketing program, which benefits communities in Africa and India.

Continue Reading

Press Releases

Two Optical Industry Veterans Make Career Moves

He will be replaced by Pete Lothes.

mm

Published

on

                 Larry Clarke and Peter Lothes

(PRESS RELEASE) BAAR, SWITZERLAND – After 19 successful years with Satisloh, first at the helm of North America and for the last 4 years as global president and group CTO, Larry Clarke takes the opportunity to pursue a new leadership role within Essilor of America. Clarke will become president, Nassau / OOGP and Optical Supplies effective January 1st, 2019. In his new role Clarke will be responsible for a portfolio of companies focusing on contact lenses, stock lenses and optical supplies.

“I am excited for this new challenge and growth opportunity and thrilled to turn over the reins at Satisloh to a successor that is more customer-focused than anyone that I have met in the optical industry,” said Clarke.

With Clarke’s move to his new role, Pete Lothes will become the new global president and CTO of Satisloh, the market leader in optical manufacturing equipment.

Lothes is a veteran of the ophthalmic industry with over 27 years of experience. He joined the industry in 1991 after graduating from college by working in the family retail and wholesale lab businesses in Columbus, Ohio. Shortly after joining the family business, he became president of the wholesale lab. The lab was acquired by Essilor Laboratories of America (ELOA) in 2004 and he continued on as its president until 2009. Later Lothes held various operational executive positions, including vice president of operations, partner labs for ELOA. He joined Satisloh in early 2015 as president of Satisloh North America. During his time there the company achieved multiple years of record sales as well as increased operational efficiencies.

“In my new role, I am looking forward to focusing on the company’s continued passion for bringing the most innovative products and processing solutions, as well as the best customer service, to all of our customers worldwide,” said Lothes.

Continue Reading

Advertisement

Advertisement

Advertisement

Most Popular